Is Lemon Bottle a Peptide? How It Is Classified
Lemon Bottle is not a peptide. It is a South Korean injectable lipolysis solution, usually described as a mix of riboflavin (vitamin B2), bromelain and lecithin, and regulators in the United States and Europe treat it as an unapproved drug, not a cosmetic. The name “lemon bottle peptide” circulates because it sits next to peptide products in search results and on social media. Chemically and legally, though, it belongs to a different category.
This guide explains what the product is, why the peptide label does not fit, how agencies classify it, and what that means if you source materials for laboratory research.
TL;DR
- Not a peptide: Lemon Bottle is marketed as a lipolytic (fat-dissolving) solution built from riboflavin, bromelain and lecithin, not from a defined peptide sequence.
- Classified as a drug: The FDA calls Lemon Bottle Ampoule Solution an unapproved new drug, and Swissmedic and the Norwegian Medical Products Agency classify it as a medicinal product because it is injected.
- Composition is unreliable: Swissmedic laboratory samples differed widely from what the label declared.
- Research use only: Peppy&Me lists Lemon Bottle strictly as a laboratory research material, not for human use, with lot-specific documentation.
What Lemon Bottle is
Lemon Bottle is a brand-name ampoule solution made in South Korea and sold for localized fat reduction on the face and body. Sellers describe it as an alternative to deoxycholic acid injections, the ingredient in the FDA-approved prescription drug Kybella. Its marketing leans on the idea that a “natural” formula is gentler than a pharmaceutical one.
The declared formula usually lists three components:
- Riboflavin (vitamin B2): a small water-soluble vitamin molecule.
- Bromelain: a mixture of protein-digesting enzymes originally extracted from pineapple.
- Lecithin: a blend of phospholipids, the fatty molecules found in cell membranes.
None of these is a signaling peptide. The concept behind the product is also different from what most researchers mean by peptide work. The claim is that the solution disrupts fat tissue locally after injection. Peptides studied in laboratories, by contrast, are typically short amino acid chains examined for how they bind receptors or influence cell signaling.
Why Lemon Bottle does not count as a peptide
A peptide is a short chain of amino acids joined by peptide bonds, usually defined as fewer than about 50 residues, with a specific sequence you can write down and verify. That sequence is what lets a lab confirm identity by mass spectrometry and purity by chromatography.
Lemon Bottle fails that test for three reasons.
- No defined active sequence. The declared actives are a vitamin, a phospholipid mixture and an enzyme blend. Only the enzyme is protein-based, and bromelain is a heterogeneous mixture of large proteins, not a single synthesized peptide.
- No single molecular identity. A peptide has one exact mass you can check against a certificate of analysis. A multi-component solution does not.
- Different proposed mechanism. The product is marketed as acting directly on fat tissue at the injection site, not as a receptor ligand.
This is the same kind of boundary researchers meet with other look-alike names. If you want to see how a genuine peptide is defined and documented, our article on whether AOD-9604 is a peptide walks through structure, origin and research status. For another naming trap, see how TB-500 differs from thymosin beta-4.
How regulators classify Lemon Bottle
Classification depends on the jurisdiction, but the direction is consistent: an injected fat-dissolving product is a drug.
United States
In a March 2025 warning letter, the FDA stated that Lemon Bottle Ampoule Solution is an unapproved new drug that is not recognized as safe and effective and cannot legally be introduced into interstate commerce without an approved application. The agency issued similar letters the same day to other firms, including a major online marketplace, over injectable lipolytic products.
The FDA’s consumer guidance on fat-dissolving injections that are not FDA approved adds that these products can be harmful and that the agency has received reports of adverse events.
Switzerland
Swissmedic, together with the cross-agency expert panel on delimitation questions, concluded in March 2024 that Lemon Bottle is a medicinal product based on its composition and its route of administration. Its warning about the illegal Lemon Bottle lipolysis solution states that the product is not authorized for the Swiss market.
Norway
The Norwegian Medical Products Agency takes the same line in its guidance that injections for fat removal are medicines, not cosmetics. Products meant to be injected to remove fat tissue are prescription medicines there.
| Jurisdiction | Body | Classification of injectable fat-dissolving products |
|---|---|---|
| United States | FDA | Unapproved new drug (Lemon Bottle named in a 2025 warning letter) |
| Switzerland | Swissmedic | Illegal medicinal product |
| Norway | Norwegian Medical Products Agency | Prescription medicine, not a cosmetic |
Some websites call Lemon Bottle a “cosmetic” or “aesthetic” product. That wording describes how it is sold, not how the agencies above classify it.
Why injection changes the category
The most common misunderstanding is that natural ingredients make an injectable safe or cosmetic. Regulators reject that logic. The Norwegian agency’s guidance explains that the administration route and intended effect, not the ingredient list or the marketing term, decide whether something is a medicine. A substance that is fine to eat or apply to skin becomes a different regulatory matter once it is placed under the skin, because sterility, endotoxin control and manufacturing quality then determine whether it is safe.
The FDA’s consumer page lists the harms it has heard about from unapproved fat-dissolving injections, including infection, scarring and tissue damage. Even approved agents need skilled handling. A systematic review of serious adverse events after deoxycholic acid injection describes complications such as swelling and nerve injury and sets out management recommendations for clinicians. An unverified product has no such clinical guidance behind it.
If you are considering a cosmetic fat-reduction procedure, talk to a licensed physician, such as a board-certified dermatologist or plastic surgeon, about FDA-approved options. This article and Peppy&Me materials are not a basis for self-injection.
What laboratory testing found in Lemon Bottle samples
The Swissmedic notice is useful for researchers because it addresses quality, not only legality. The agency’s laboratory analysis of seized samples found that the contents did not reliably match the declared ingredients. Composition varied widely between samples, and some lacked declared ingredients.
That finding is the practical reason the peptide question matters. A product with a vague composition cannot be assigned a clear identity, and an unclear identity makes any research result hard to interpret or reproduce.
What this means if you source research materials
For a researcher, the lesson from Lemon Bottle is about documentation. Before you use any compound in a study, you should be able to answer four questions:
- What exactly is it? Identity confirmed by mass accuracy, not by the label.
- How pure is it? A purity percentage from an independent lab, tied to a specific lot.
- Is it clean? Sterility, endotoxin and heavy metal results for that lot.
- Can you trace it? A lot or batch number that follows the material from manufacturer to warehouse.
At Peppy&Me, products are third-party tested for purity, mass accuracy, endotoxins, sterility and heavy metals, and lot and batch numbers are traceable. Our guide to the five COA tests that matter for lab researchers shows how to read these reports.
It also helps to understand why many research compounds are sold under a research-use-only label. The FDA’s approval path is expensive, requires extensive clinical trials and usually needs commercial backing. Naturally occurring or hard-to-patent compounds often attract less funding, even when scientific interest continues. We explain the consequences in why the FDA reclassified 19 peptides as research use only and in five FDA signals that drug approval does not apply to RUO material. Research-use-only status is a compliance boundary: it does not imply any human use, benefit or safety.
Lemon Bottle at Peppy&Me
Peppy&Me lists a Lemon Bottle research listing for authorized adults aged 21 and over working in laboratory or scientific settings. It is offered for laboratory research use only, not for injection into people or animals, not as a cosmetic and not as a supplement. The listing is not a claim that the product is a peptide, and nothing on this page suggests it is approved or effective for fat reduction.
Members can log in, track orders and review lot documentation. Orders placed before 2 PM ship the same day within the U.S., and the built-in dose calculator and peptide glossary support lab-side planning for the peptides in the full research compounds catalog.
Our perspective
We get asked about Lemon Bottle often, usually phrased as a peptide question. Our answer is direct: it is not one, and we would rather say so than let a search term blur the category. Peptides are defined, sequence-specific molecules that a lab can verify. A multi-ingredient injectable with documented composition problems is something else.
We built Peppy&Me around the idea that a research material should come with proof. That means independent testing for purity, mass accuracy, endotoxins, sterility and heavy metals on every lot, plus traceable batch numbers, so a researcher knows what is in the vial before work begins. We keep strictly to research-use-only compliance because a clear boundary protects researchers and the public. We do not make disease, treatment or results claims for any product.
If you want to learn the language of this field, start with the glossary and the dose calculator, and read the COA before you read the marketing.
— Peppy&Me
What real peptides look like in comparison
Contrasting Lemon Bottle with compounds that are peptides clarifies the line. Our reference articles describe each in terms researchers can check:
- Semaglutide: one molecule that appears under several FDA labels.
- Retatrutide and the “GLP-3” nickname: three receptor targets that researchers must keep distinct.
- Epitalon: a short peptide with a recent regulatory timeline.
- GLOW and KLOW blends: defined multi-peptide research materials with COA checklists.
Each of these has a stated molecular identity that a certificate of analysis can confirm. That is the practical test for the word peptide.
FAQ
Is Lemon Bottle a peptide?
No. It is described as a lipolytic solution containing riboflavin, bromelain and lecithin, not a defined peptide sequence. The “lemon bottle peptide” phrase is a search habit, not a chemical description.
Is Lemon Bottle FDA approved?
No. In March 2025 the FDA called Lemon Bottle Ampoule Solution an unapproved new drug that cannot legally be shipped across state lines without an approved application. The only FDA-approved injectable of this kind is deoxycholic acid, which is a separate product.
Is Lemon Bottle a drug or a cosmetic?
Regulators in the U.S., Switzerland and Norway treat injectable fat-dissolving products as drugs or medicines. Calling it cosmetic reflects marketing, and Swissmedic and the Norwegian agency specifically reject that label for injected products.
Does the product need refrigeration or special handling?
Storage depends on the manufacturer’s documentation for the specific lot, and the contents of different samples have been shown to vary. Researchers should rely on the lot’s COA and handling instructions, and anyone with a medical question should ask a licensed physician.
Sources
- FDA warning letter to Filler Lux, March 2025
- FDA warning letter to Amazon.com, March 2025
- FDA: Using fat-dissolving injections that are not FDA approved can be harmful
- Swissmedic warning about the illegal medicinal product Lemon Bottle
- Norwegian Medical Products Agency: injections for fat removal are medicines
- Management of serious adverse events following deoxycholic acid injection (PMC)